The origin and evolution of mutations in acute myeloid leukemia

Welch, John S., Ley, Timothy J., Link, Daniel C., Miller, Christopher A., Larson, David E., Koboldt, Daniel C., Wartman, Lukas D., Lamprecht, Tamara L. +46 more·2012·Cell

Cited by (1,001)

Items 101–200 of 1,001

  1. Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
    Eric J. Duncavage, Molly C. Schroeder, Michele O’Laughlin, Roxanne Wilson, Sandra MacMillan, Andrew S. Bohannon, Scott S. Kruchowski, John E. Garza, Feiyu Du, Andrew E. O. Hughes et al. · 2021 · New England Journal of Medicine
  2. Recent advances in targeted therapies in acute myeloid leukemia
    Rahul S. Bhansali, Keith William Pratz, Catherine Lai · 2023 · Journal of Hematology & Oncology
  3. Life histories of myeloproliferative neoplasms inferred from phylogenies
    Williams, Nicholas, Lee, Joe, Mitchell, Emily, Moore, Luiza, Baxter, E. Joanna, Hewinson, James, Dawson, Kevin J., Menzies, Andrew, Godfrey, Anna L., Green, Anthony R. et al. · 2022 · Nature
  4. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
    Walter, M J, Shen, D, Shao, J, Ding, L, White, B S, Kandoth, C, Miller, C A, Niu, B, McLellan, M D, Dees, N D et al. · 2013 · Leukemia
  5. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    Fiskus, W, Sharma, S, Shah, B, Portier, B P, Devaraj, S G T, Liu, K, Iyer, S P, Bearss, D, Bhalla, K N · 2014 · Leukemia
  6. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Y. Kikushige, T. Miyamoto, Junichiro Yuda, S. Jabbarzadeh-Tabrizi, T. Shima, Shin-ichiro Takayanagi, H. Niiro, Ayano Yurino, K. Miyawaki, K. Takenaka et al. · 2015 · Cell Stem Cell
  7. Age-related clonal hematopoiesis
    Shlush, Liran I. · 2018 · Blood
  8. Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics
    Charles Gawad, Winston Lian Chye Koh, Stephen R. Quake · 2014 · Proceedings of the National Academy of Sciences
  9. Precision oncology for acute myeloid leukemia using a knowledge bank approach
    Moritz Gerstung, Elli Papaemmanuil, Sancha Martin, Lars Bullinger, Verena I. Gaidzik, Peter Paschka, Michael Heuser, Felicitas R. Thol, Niccolò Bolli, Peter S. Ganly et al. · 2017 · Nature Genetics
  10. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
    Jan Krönke, Lars Bullinger, Veronica Teleanu, Florian Tschürtz, Verena I. Gaidzik, Michael W.M. Kühn, Frank G. Rücker, Karlheinz Holzmann, Peter Paschka, Silke Kapp‐Schwoerer et al. · 2013 · Blood
  11. The genomic landscape of core-binding factor acute myeloid leukemias
    Zachary J. Faber, Xiang 'Anthony' Chen, Amanda Larson Gedman, Kristy Boggs, Jinjun Cheng, Jing Ma, Ina Radtke, Jyh-Rong Chao, Michael P. Walsh, Guangchun Song et al. · 2016 · Nature Genetics
  12. Polytherapy and Targeted Cancer Drug Resistance
    Nilanjana Chatterjee, Trever Grant Bivona · 2019 · Trends in cancer
  13. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
    Cristina Balbás-Martínez, Ana María Alfaro de Prado Sagrera, Enrique Carrillo de Santa Pau, Julie Earl, Mirari Márquez, Miguél Vázquez, Eleonora Lapi, Francesc Castro-Giner, Sergi Beltrán, Mónica Bayés et al. · 2013 · Nature Genetics
  14. Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
    Frédérik Damm, Elena Mylonas, Adrien Cosson, Kenichi Yoshida, Véronique Della-Valle, Enguerran Mouly, M'boyba Khadija Diop, Laurianne Scourzic, Yuichi Shiraishi, Kenichi Chiba et al. · 2014 · Cancer Discovery
  15. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
    Austin Gladston Kulasekararaj, Jie Jiang, Alexander Smith, Azim M. Mohamedali, Syed A. Mian, Shreyans Gandhi, Joop A. Gäken, Barbara H. Czepulkowski, Judith C. W. Marsh, Ghulam Jeelani Mufti · 2014 · Blood
  16. Leukemic stem cells and therapy resistance in acute myeloid leukemia
    Patrick Stelmach, Andreas Trumpp · 2023 · Haematologica
  17. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells
    Zhang, Xiaotian, Su, Jianzhong, Jeong, Mira, Ko, Myunggon, Huang, Yun, Park, Hyun Jung, Guzman, Anna, Lei, Yong, Huang, Yung-Hsin, Rao, Anjana et al. · 2016 · Nature Genetics
  18. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
    Guryanova, Olga A, Shank, Kaitlyn, Spitzer, Barbara, Luciani, Luisa, Koche, Richard P, Garrett-Bakelman, Francine E, Ganzel, Chezi, Durham, Benjamin H, Mohanty, Abhinita, Hoermann, Gregor et al. · 2016 · Nature Medicine
  19. Mosaicism in health and disease — clones picking up speed
    Lars Anders Forsberg, David Gisselsson, Jan Piotr Dumanski · 2016 · Nature Reviews Genetics
  20. Clonal expansion in non-cancer tissues
    Kakiuchi, Nobuyuki, Ogawa, Seishi · 2021 · Nature Reviews Cancer
  21. FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?
    Mark J. Levis · 2013 · Hematology
  22. FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
    Antar, Ahmad I., Otrock, Zaher K., Jabbour, Elias, Mohty, Mohamad, Bazarbachi, Ali · 2020 · Leukemia
  23. Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
    Shih, Alan H., Jiang, Yanwen, Meydan, Cem, Shank, Kaitlyn, Pandey, Suveg, Barreyro, Laura, Antony-Debre, Ileana, Viale, Agnes, Socci, Nicholas, Sun, Yongming et al. · 2015 · Cancer Cell
  24. Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
    Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi, Takeharu Kato, Eiko Yamamoto, Kyogo Suzuki, Fangli Chen, Norio Asou, Shigeki Ohtake, Shuichi Miyawaki et al. · 2014 · Leukemia
  25. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer
    Ruoyan Li, John R. Ferdinand, Kevin W. Loudon, Georgina Bowyer, Sean Laidlaw, Francesc Muyas, Lira Mamanova, Joana Briosa Neves, Liam Bolt, Eirini Sofia Fasouli et al. · 2022 · Cancer Cell
  26. Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis
    Fernando G. Osorio, Axel Rosendahl Huber, Rurika Oka, Mark Verheul, Sachin H Patel, Karlijn Hasaart, Lisanne de la Fonteijne, Ignacio Varela, Fernando D. Camargo, Ruben van Boxtel · 2018 · Cell Reports
  27. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
    Vaia Stavropoulou, Susanne Kaspar, Laurent Brault, Mathijs Arnoud Sanders, Sabine Juge, Stefano Morettini, Alexandar Tzankov, Michelina Iacovino, I‐Jun Lau, Thomas A. Milne et al. · 2016 · Cancer Cell
  28. Measurable residual disease testing in acute myeloid leukaemia
    Christopher Simon Hourigan, Robert Peter Gale, Nicole J. Gormley, Gert Jan Ossenkoppele, Roland B. Walter · 2017 · Leukemia
  29. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
    Jane E. Churpek, Khateriaa Pyrtel, K. Kanchi, Jin Shao, Daniel C. Koboldt, Christopher A. Miller, Dong Shen, Robert S. Fulton, Michelle D. O’Laughlin, Catrina C. Fronick et al. · 2015 · Blood
  30. The Role of Telomeres in Stem Cells and Cancer
    Çagatay Güneş, K. Lenhard Rudolph · 2013 · Cell
  31. Cohesin in cancer: chromosome segregation and beyond
    Ana Losada · 2014 · Nature reviews. Cancer
  32. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
    Xiongwei Cai, Long Gao, Li Teng, Jingping Ge, Zaw Min Oo, Ashish R. Kumar, Dwight Gary Gilliland, Philip J. Mason, Kai Tan, Nancy A. Speck · 2015 · Cell stem cell
  33. Chronic immune response dysregulation in MDS pathogenesis
    Barreyro, Laura, Chlon, Timothy M., Starczynowski, Daniel T. · 2018 · Blood
  34. The influence of subclonal resistance mutations on targeted cancer therapy
    Michael W. Schmitt, Lawrence A. Loeb, Jesse J. Salk · 2015 · Nature Reviews Clinical Oncology
  35. High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics
    Maurizio Pellegrino, Adam Sciambi, Sebastian Treusch, Robert Durruthy-Durruthy, Kaustubh Gokhale, Jose P. Jacob, Tina X. Chen, Jennifer A. Geis, William M. Oldham, Jairo A. Matthews et al. · 2018 · Genome Research
  36. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
    Eric J. Duncavage, Adam Bagg, Robert Paul Hasserjian, Courtney Denton Dinardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro Maria Vannucchi, Keyur Pravinchandra Patel et al. · 2022 · Blood
  37. IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
    de Botton, Stephane, Mondesir, Johanna, Willekens, Christophe, Touat, Mehdi · 2016 · Journal of Blood Medicine
  38. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
    Frédérik Damm, Virginie Chesnais, Yasunobu Nagata, Kenichi Yoshida, Laurianne Scourzic, Yusuke Okuno, Raphaël Itzykson, Masashi Sanada, Yuichi Shiraishi, Véronique Gelsi‐Boyer et al. · 2013 · Blood
  39. Telomere Dynamics in Mice and Humans
    Calado, Rodrigo T., Dumitriu, Bogdan · 2013 · Seminars in Hematology
  40. Emergence of New ALK Mutations at Relapse of Neuroblastoma
    Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaëlle Pierron, Eve Lapouble, Valérie Combaret, Frank Speleman et al. · 2014 · Journal of Clinical Oncology
  41. Aging and the rise of somatic cancer-associated mutations in normal tissues
    Rosa Ana Risques, Scott R. Kennedy · 2018 · PLoS Genetics
  42. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
    Manoj Garg, Yasunobu Nagata, Deepika Kanojia, Anand Mayakonda, Kenichi Yoshida, Sreya Haridas Keloth, Zhi Jiang Zang, Yusuke Okuno, Yuichi Shiraishi, Kenichi Chiba et al. · 2015 · Blood
  43. Impact of genomic damage and ageing on stem cell function
    Behrens, Axel, van Deursen, Jan M., Rudolph, K. Lenhard, Schumacher, Björn · 2014 · Nature Cell Biology
  44. Frequent truncating mutations of STAG2 in bladder cancer
    David A. Solomon, Jung-Sik Kim, Jolanta E. Bondaruk, Shahrokh François Shariat, Zeng-Feng Wang, ABDEL G. ELKAHLOUN, Tomoko Ozawa, Julia Gerard, Dazhong Zhuang, Shizhen Zhang et al. · 2013 · Nature Genetics
  45. A review of FLT3 inhibitors in acute myeloid leukemia
    Jennifer C. Zhao, Sonal Agarwal, Hiba Ahmad, Kejal Amin, Jan Philipp Bewersdorf, Amer Methqal Zeidan · 2021 · Blood Reviews
  46. Clonal hematopoiesis in acquired aplastic anemia
    Seishi Ogawa · 2016 · Blood
  47. Cancer: Evolution Within a Lifetime
    Marco Gerlinger, Nicholas McGranahan, Sally M. Dewhurst, Rebecca A. Burrell, Ian P.M. Tomlinson, Charles Swanton · 2014 · Annual Review of Genetics
  48. Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
    Dyantha I. van der Lee, Rogier M. Reijmers, Maria W. Honders, Renate S. Hagedoorn, Rob C. M. de Jong, Michel G.D. Kester, Dirk M. van der Steen, Arnoud H. de Ru, Christiaan Kweekel, Helena M. Bijen et al. · 2019 · Journal of Clinical Investigation
  49. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
    Terrence Neal Wong, Christopher A. Miller, Matthew R. M. Jotte, Nusayba Ali Bagegni, Jack Baty, Amy P. Schmidt, Amanda F. Cashen, Eric J. Duncavage, Nichole Helton, Mark Aaron Fiala et al. · 2018 · Nature Communications
  50. RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
    Ulrike Höckendorf, Monica Yabal, Tobias Herold, Enkhtsetseg Munkhbaatar, Stephanie Rott, Stefanie Jilg, Johanna Kauschinger, Giovanni Magnani, Florian Reisinger, Michael Heuser et al. · 2016 · Cancer Cell
  51. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
    Felicitas R. Thol, Robin Bollin, Marten A. Gehlhaar, Carolin Walter, Martin Dugas, Karl Josef Suchanek, Aylin Kirchner, Liu Huang, Anuhar Chaturvedi, Martin Wichmann et al. · 2013 · Blood
  52. Genetic and epigenetic heterogeneity in acute myeloid leukemia
    Sheng Li, Christopher E. Mason, Ari M. Melnick · 2016 · Current Opinion in Genetics & Development
  53. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
    Arends, Christopher Maximilian, Galan-Sousa, Joel, Hoyer, Kaja, Chan, Willy, Jäger, Marten, Yoshida, Kenichi, Seemann, Ricarda, Noerenberg, Daniel, Waldhueter, Nils, Fleischer-Notter, Helga et al. · 2018 · Leukemia
  54. Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
    Satoshi Inoue, Wanda Y. Li, Alan Tseng, Isabel Beerman, Andrew Elia, Sean C. Bendall, François Lemonnier, Ken J. Kron, David W. Cescon, Zhenyue Hao et al. · 2016 · Cancer Cell
  55. Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
    Julien Ablain, Kim L. Rice, Hassane Soilihi, Aurélien de Reyniès, Saverio Minucci, Hugues de Thé · 2014 · Nature Medicine
  56. Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
    Hiu Ting Chan, Yoon Ming Chin, Yusuke Nakamura, Siew‐Kee Low · 2020 · Cancers
  57. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination
    Zack Sanborn, Jongsuk Chung, Elizabeth A. Purdom, Nicholas J. Wang, Hojabr Kakavand, James S. Wilmott, Timothy M. Butler, John F. Thompson, Graham J. Mann, Lauren Elaine Haydu et al. · 2015 · Proceedings of the National Academy of Sciences
  58. Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis
    Catherine Choy Smith, Amy L. Paguirigan, Grace R. Jeschke, Kimberly C. Lin, Evan Massi, Theodore C. Tarver, Chen-Shan Chin, Saurabh Asthana, Adam B. Olshen, Kevin J. Travers et al. · 2017 · Blood
  59. KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
    Burgess, Michael R., Hwang, Eugene, Mroue, Rana, Bielski, Craig M., Wandler, Anica M., Huang, Benjamin J., Firestone, Ari J., Young, Amy, Lacap, Jennifer A., Crocker, Lisa et al. · 2017 · Cell
  60. Clonal hematopoiesis and non-hematologic disorders
    Jaiswal, Siddhartha · 2020 · Blood
  61. Minimal residual disease in acute myeloid leukaemia
    Christopher Simon Hourigan, Judith E. Karp · 2013 · Nature Reviews Clinical Oncology
  62. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Carolyn S. Grove, George S. Vassiliou · 2014 · Disease Models & Mechanisms
  63. C. eleganswhole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency
    Bettina Meier, Susanna L. Cooke, Joerg Weiss, Aymeric Bailly, Ludmil B. Alexandrov, John Marshall, Keiran M. Raine, Mark Maddison, Elizabeth L. Anderson, Michael R. Stratton et al. · 2014 · Genome Research
  64. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring
    Raja Luthra, Keyur Pravinchandra Patel, Neelima G. Reddy, Varan Haghshenas, Mark J. Routbort, Margaret A. Harmon, Bedia A. Barkoh, Rashmi Kanagal‐Shamanna, Farhad Ravandi, Jörge E. Cortes et al. · 2013 · Haematologica
  65. Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
    Akihiro Tomita, Hitoshi Kiyoi, Tomoki Naoe · 2013 · International Journal of Hematology
  66. Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease
    Isabel Beerman, Derrick J. Rossi · 2015 · Cell stem cell
  67. Genetics of progression from MDS to secondary leukemia
    Andrew J. Menssen, Matthew J. Walter · 2020 · Blood
  68. BreakDancer: Identification of Genomic Structural Variation from Paired‐End Read Mapping
    Xian Fan, Travis E. Abbott, David E. Larson, Ken Chen · 2014 · Current Protocols in Bioinformatics
  69. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
    Kotini, Andriana G, Chang, Chan-Jung, Boussaad, Ibrahim, Delrow, Jeffrey J, Dolezal, Emily K, Nagulapally, Abhinav B, Perna, Fabiana, Fishbein, Gregory A, Klimek, Virginia M, Hawkins, R David et al. · 2015 · Nature Biotechnology
  70. Causes and consequences of clonal hematopoiesis
    Weeks, Lachelle D., Ebert, Benjamin L. · 2023 · Blood
  71. Somatic stem cell heterogeneity: diversity in the blood, skin and intestinal stem cell compartments
    M. Goodell, Hoang Nguyen, N. Shroyer · 2015 · Nature reviews. Molecular cell biology
  72. Clonal evolution in hematological malignancies and therapeutic implications
    Dan Avi Landau, Scott L. Carter, Gad A. Getz, Catherine J. Wu · 2013 · Leukemia
  73. FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
    Naval Guastad Daver, Sangeetha Venugopal, Farhad Ravandi · 2021 · Blood Cancer Journal
  74. Why does the bone marrow fail in Fanconi anemia?
    Juan I. Garaycoechea, Ketan J. Patel · 2013 · Blood
  75. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis
    Julia Skokowa, Doris Steinemann, Jenny E. Katsman-Kuipers, Cornelia Zeidler, Olga Klimenkova, Maksim Klimiankou, Murat Ünalan, Siarhei Kandabarau, Vahagn Makaryan, Renée Beekman et al. · 2014 · Blood
  76. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data
    Huilei Xu, John DiCarlo, Ravi Vijaya Satya, Quan Peng, Yexun Wang · 2014 · BMC Genomics
  77. Bacteria-Human Somatic Cell Lateral Gene Transfer Is Enriched in Cancer Samples
    David R. J. Riley, Karsten B. Sieber, Kelly M. Robinson, James Robert White, Ashwinkumar Ganesan, Syrus Nourbakhsh, Julie C. Dunning Hotopp · 2013 · PLoS Computational Biology
  78. Somatic Mutations and Clonal Hematopoiesis
    José J. Fuster, Kenneth Walsh · 2018 · Circulation Research
  79. Cardiovascular Disease, Aging, and Clonal Hematopoiesis
    Megan A. Evans, Soichi Sano, Kenneth Walsh · 2019 · Annual Review of Pathology Mechanisms of Disease
  80. Myeloproliferative neoplasms: from origins to outcomes
    Jyoti Nangalia, Anthony Richard Green · 2017 · Blood
  81. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia
    Amy L. Paguirigan, Jordan L. Smith, Soheil Meshinchi, Martin P Carroll, Carlo C. Maley, Jerald P. Radich · 2015 · Science Translational Medicine
  82. CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
    Ugo Testa, Elvira Pelosi, Germana Castelli · 2019 · Cancers
  83. Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
    Aaron D. Viny, Christopher J. Ott, Barbara G. Spitzer, Martín A. Rivas, Cem Meydan, Efthymia Papalexi, Dana Yelin, KAITLYN R. SHANK, Jaime M. Reyes, April Chiu et al. · 2015 · The Journal of Experimental Medicine
  84. Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution
    Ryutaro Uchi, Yusuke Takahashi, Atsushi Niida, Teppei Shimamura, Hidenari Hirata, Keishi Sugimachi, Genta Sawada, Takeshi Iwaya, Junji Kurashige, Yoshiaki Shinden et al. · 2016 · PLoS Genetics
  85. A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations
    Mark J. Levis, Alexander E. Perl, Jessica Kaplan Altman, Christopher D. Gocke, Erkut Bahceci, Jason E. Hill, Chaofeng Liu, Zhiyi Xie, Andrew R. Carson, Valerie McClain et al. · 2018 · Blood Advances
  86. FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance
    Michael Richard Grunwald, Mark J. Levis · 2013 · International Journal of Hematology
  87. Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience
    Dorota M. Rowczenio, Sonia Melo Gomes, Juan I. Aróstegui, Anna Mensa‐Vilaró, Ebun Omoyinmi, Hadija Trojer, Anna Baginska, Alberto Baroja‐Mazo, Pablo Pelegrı́n, Sinisa Savic et al. · 2017 · Frontiers in Immunology
  88. Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia
    Tim Grob, Mathijs Arnoud Sanders, Christian M. Vonk, F. G. Kavelaars, Melissa Rijken, Diana Hanekamp, Patrycja L. Gradowska, Jacqueline J Cloos, Yngvar Fløisand, Marinus van Marwijk Kooy et al. · 2022 · Journal of Clinical Oncology
  89. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis
    Holstege, Henne, Pfeiffer, Wayne, Sie, Daoud, Hulsman, Marc, Nicholas, Thomas J., Lee, Clarence C., Ross, Tristen, Lin, Jue, Miller, Mark A., Ylstra, Bauke et al. · 2014 · Genome Research
  90. Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
    on behalf of the International CML Foundation Genomics Alliance, Branford, Susan, Kim, Dennis Dong Hwan, Apperley, Jane F., Eide, Christopher A., Mustjoki, Satu, Ong, S. Tiong, Nteliopoulos, Georgios, Ernst, Thomas, Chuah, Charles et al. · 2019 · Leukemia
  91. Clonal evolution in myelodysplastic syndromes
    Pedro da Silva-Coelho, Leonie I. Kroeze, Kenichi Yoshida, Theresia N. Koorenhof‐Scheele, Ruth Knops, Louis T. van de Locht, Aniek O. de Graaf, Marion Massop, Sarah Sandmann, Martin Dugas et al. · 2017 · Nature Communications
  92. The success and the challenge of all-trans retinoic acid in the treatment of cancer
    Xiaoling Ni, Guohua Hu, Xun Cai · 2018 · Critical Reviews in Food Science and Nutrition
  93. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
    Chan‐Wang Jerry Lio, Hiroshi Yuita, Anjana Rao · 2019 · Blood
  94. Detecting Somatic Mutations in Normal Cells
    Yanmei Dou, Heather D. Gold, Lovelace J. Luquette, Peter J. Park · 2018 · Trends in Genetics
  95. Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches
    Ravi G. Gupta, Fenge Li, Jason Roszik, Gregory A. Lizee · 2021 · Cancer Discovery
  96. Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation
    Bartlomiej M. Getta, Sean M. Devlin, Ross L. Levine, Maria E. Arcila, Abhinita S. Mohanty, Ahmet Zehir, Martin S. Tallman, Sergio A. Giralt, Mikhail Roshal · 2017 · Transplantation and Cellular Therapy
  97. Using tumour phylogenetics to identify the roots of metastasis in humans
    Kamila Naxerova, Rakesh K. Jain · 2015 · Nature Reviews Clinical Oncology
  98. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups
    Ursula Creutzig, Martin Zimmermann, Dirk Reinhardt, Mareike Rasche, Christine von Neuhoff, Tamara Alpermann, Michael Norbert Dworzak, Karolína Perglerová, Zuzana Zemanová, Joëlle Tchinda et al. · 2016 · Cancer
  99. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
    Friederike Christen, Kaja Hoyer, Kenichi Yoshida, Hsin‐An Hou, Nils Waldhüter, Michael Heuser, Robert Kerrin Hills, Willy Chan, Raphael Hablesreiter, Olga Blau et al. · 2019 · Blood
  100. Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis
    M. Ryan Corces, Ravindra Majeti · 2014 · Leukemia